Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery

Postoperative ctDNA status is a robust biomarker predicting recurrence risk and ACT benefit in patients with rectal cancer undergoing upfront surgery.

Authors

Institutions

Publication Details

Journal
Annals of Surgery
Published
2025-09-26
DOI
https://doi.org/10.1097/sla.0000000000006948
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery

Kentaro Yamazaki, Matthew Rabinowitz, Yoshiaki Nakamura, Masaaki Miyo et al.
Annals of Surgery
Cancer Genomics and Diagnostics
article

Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery

Kentaro Yamazaki, Matthew Rabinowitz, Yoshiaki Nakamura, Masaaki Miyo, Kentaro Kato, Yoshinori Kagawa, Adham Jurdi, Atsushi Hamabe, Koji Ando, Naoya Akazawa, Ichiro Takemasa, Minetta C. Liu, Jun Watanabe, Daisuke Kotani, Kozo Kataoka, George Laliotis, Hideaki Bando, Hiroki Yukami, Takayuki Yoshino, Eiji Oki, Alexey Aleshin, Hiroya Taniguchi, Keiji Hirata, Mitsuru Yokota, Charuta C. Palsuledesai, Takeshi Kato, Shruti Sharma, Saori Mishima
article en

Abstract

Postoperative ctDNA status is a robust biomarker predicting recurrence risk and ACT benefit in patients with rectal cancer undergoing upfront surgery.

Annals of SurgeryVol. 283(1)
Kansai Medical University (JP), Kyushu University (JP), Sapporo Medical University (JP), University of Occupational and Environmental Health Japan (JP), Yokohama City University Medical Center (JP), Osaka Prefectural Medical Center (JP), Shizuoka Cancer Center (JP), Kurashiki Central Hospital (JP), Osaka National Hospital (JP), Osaka City General Hospital (JP), Sendai Medical Center (JP), Osaka Hospital (JP), Natera (United States) (US), Aichi Cancer Center (JP), Teine Keijinkai Hospital (JP), National Cancer Center Hospital East (JP), Osaka International Cancer Institute (JP), Hyogo University (JP), Yokohama City University (JP), Osaka University of Pharmaceutical Sciences (JP), The University of Osaka (JP)
Openalex Percentile: Top 68%
Cancer Genomics and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.